• Presented at ISPOR Europe (2024)

  • Collaborator: Janssen

  • Authors: Laury Sellem, Julie Laurent, Lise Radoszycki

Around 900,000 adults in the United States (US) suffer from multiple sclerosis (MS), one of the most common progressive neurologic disease in young adults. Most MS patients suffer from fatigue, which is one of the main causes of their impacted quality of life. The Fatigue Symptoms and Impacts Questionnaire – Relapsing Multiple Sclerosis (FSIQ-RMS) is a disease-specific tool designed to assesses its impact on quality of life from a patient perspective.
This study aimed to identify the factors impacting FSIQ-RMS scores over time in RMS patients from
the US.